(3) Stage-adaptive targeting addresses evolving plaque biology [142], with PBNs unique hemodynamic stability enabling: (i) endothelial activation/neutrophil recruitment during early atherogenesis, (ii) foam cell/collagen fiber targeting in progressive plaques, and (iii) thrombus/necrotic core engagement in unstable lesions [99]
Three-year outcomes of post-acute sequelae of COVID-19
The appropriate amount, frequency, concentration, injection schedule, and treatment duration may vary according to the patients medical history, treatment goals, formulation, laboratory findings when appropriate, clinical response, and prescribing providers instructions
Although KD significantly limits carbohydrate intake, it maintains the minimum carbohydrate supply necessary for gluconeogenesis (257)